PRO MEDICUS LIMITED — Capital/Financing Update 2015

Aug 25, 2015

==> picture [162 x 34] intentionally omitted <==

Pro Medicus Limited 450 Swan Street Richmond Victoria 3121 Australia T +61 3 9429 8800 F +61 3 9429 9455 promedicus.com

Wednesday 26 August 2015

Exercise of Share Options

Leading medical imaging company Pro Medicus (ASX: PME) today announced the exercise of 10,000 share options under the company’s Employee Share Options Plan (ESOP).

Appendix 3B covering the exercise of these share options is attached.

For further information:

Dr Sam Hupert Chief Executive Officer Pro Medicus Limited Ph: +613 94298800

Mr. Clayton Hatch Company Secretary Pro Medicus Limited Ph: +613 94298800

Pro Medicus Limited ABN 25 006 194 752

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

Pro Medicus Limited

ABN

25 006 194 752

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1+Class of+securities issued or to beissued2Number of+securities issued or to beissued (if known) or maximumnumber which may be issued3Principal terms of the+securities (eg,if options, exercise price and expirydate; if partly paid+securities, theamount outstanding and due dates forpayment; if+convertible securities,the conversion price and dates forconversion)	Ordinary full paid
	10,000
	Exercise price – $1.00Expiry date – 1 April 2020

Appendix 3B New issue announcement

4Do the+securities	4Do the+securities	rank equally in all	rank equally in all	Yes
respects from thewith an existing		date of allotment+class of quoted
+securities?
If the additional		securities do not
rank equally, please state: the date from which they do theextenttowhichtheyparticipate for the next dividend,(inthecaseofatrust,diibi i
struton) or the extent to		nterest paymentwhich they do notother than ine next dividend,
rank equally,
relation to th
distribution or		interest payment
5Issue price or cons		ideration		Refer Part 1, Item	3 above
6Purpose of the issu		e	I	ssued pursuant to	an exercise of opti		ons
		sideration for the
	(If issued as con
	acquisition of asse	ts, clearly identify
those assets)	those assets)
		g+securities intoldings or despatch
7D f i
			2	6 August 2015
ates o entertifitd h
uncercaeof certificates
			Number			+Class
			100,323,406			Ordinary

Appendix 3B New issue announcement

9Number and+class of all+securitiesnot quoted on ASX (_including_thesecurities in clause 2 if applicable)10Dividend policy (in the case of atrust, distribution policy) on theincreased capital (interests)	Number	+Class
	1,615,000 share options1,196,875 performancerights	200,000 options withexpiry date 12 March2018.715,000 options withexpiry date 1 April2020.500,000 options withexpiry date 25 August2020.200,000 options withexpirydate18November 2021.1,196,875performancerightswith nil expirydate
	All shares to rank equally

Part 2 - Bonus issue or pro rata issue

11 Is security holder approval required? 12 Is the issue renounceable or nonrenounceable? 13 Ratio in which the[+] securities will be offered 14 +Class of +securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions

Appendix 3B Page 3

Appendix 3B New issue announcement

18Names of countries in which theentity has+security holders who willnot be sent new issue documentsNote: Security holders must be told how theirentitlements are to be dealt with.Cross reference: rule 7.7.19Closingdateforreceiptofacceptances or renunciations20Names of any underwriters21Amount of any underwriting fee orcommission22Names of any brokers to the issue23Fee or commission payable to thebroker to the issue24Amount of any handling fee payableto brokers who lodge acceptances orrenunciations on behalf of+securityholders25If the issue is contingent on+securityholders’ approval, the date of themeeting26Date entitlement and acceptanceform and prospectus or ProductDisclosure Statement will be sent topersons entitled27If the entity has issued options, andthe terms entitle option holders toparticipate on exercise, the date onwhich notices will be sent to optionholders28Date rights trading will begin (ifapplicable)29Date rights trading will end (ifapplicable)30How do+security holders sell theirentitlements_in full_through abroker?

Appendix 3B Page 4

Appendix 3B New issue announcement

31 How do[+] security holders sell part of their entitlements through a broker and accept for the balance?

32 How do[+] security holders dispose of their entitlements (except by sale through a broker)? 33 +Despatch date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of securities ( tick one )

• (a)[Securities described in Part 1 ]

• (b)[All other securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37 A copy of any trust deed for the additional[+] securities

Appendix 3B Page 5

Appendix 3B New issue announcement

Entities that have ticked box 34(b)

38 Number of securities for which +quotation is sought 39 Class of +securities for which quotation is sought 40 Do the[+] securities rank equally in all respects from the date of allotment with an existing[+] class of quoted +securities? If the additional securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security) Number +Class 42 Number and[+] class of all[+] securities quoted on ASX ( including the securities in clause 38)

Appendix 3B Page 6

Appendix 3B New issue announcement

Quotation agreement

• 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

• 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

• If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

• 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: Date 26 August 2015 Company Secretary

Print name: Clayton Hatch

Appendix 3B Page 7